Integrating the result from PPI network, Oncomine Platform, and survival analysis, EGFR, FLT1, and EDN1 were considered as key factors in the prognosis of ccRCC and potential targets for the treatment of ccRCC. This evidence concerns the gene EDN1 and nonpapillary renal cell carcinoma.